It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Shorter people are at risk for cardiovascular disease (CVD), but data remain limited. This study sought to determine whether height loss is associated with an increased incidence of CVD. From the Korean National Health Insurance Service—Senior database (2002–2015), data of 134,952 individuals with available information on height loss was obtained. Height loss as percentages was measured 3–5 years from the baseline height. To assess hazard ratios for CVD incidence, multivariable Cox proportional hazard regression models were used before and after applying propensity score matching. The unmatched cohort consisted of 109,546 participants without height loss (< 1%): 20,208 participants with 1–2% height loss, and 5126 participants with ≥ 2% height loss. During a median follow-up period of 6.5 years (interquartile range, 3.7–8.5 years), 21,921 were newly diagnosed with CVD. Adults with height loss of > 2% had a greater risk of incident CVD than those with no height loss. This finding was statistically significant both in the original- and propensity score-matched cohorts. The increased risk for ischemic stroke was significant in the male subgroups, in line with degree of height loss. Overall, height loss is associated with an increased risk of subsequent ischemic stroke in Korean men.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Gachon University College of Medicine, Department of Family Medicine, Gil Medical Center, Incheon, South Korea (GRID:grid.256155.0) (ISNI:0000 0004 0647 2973)
2 Gachon University College of Medicine, Artificial Intelligence and Big-Data Convergence Center, Gil Medical Center, Incheon, South Korea (GRID:grid.256155.0) (ISNI:0000 0004 0647 2973)
3 Gachon University College of Medicine, Artificial Intelligence and Big-Data Convergence Center, Gil Medical Center, Incheon, South Korea (GRID:grid.256155.0) (ISNI:0000 0004 0647 2973); Seoul National University, Graduate School of Public Health, Seoul, South Korea (GRID:grid.31501.36) (ISNI:0000 0004 0470 5905)
4 Gachon University College of Medicine, Artificial Intelligence and Big-Data Convergence Center, Gil Medical Center, Incheon, South Korea (GRID:grid.256155.0) (ISNI:0000 0004 0647 2973); Gachon University College of Medicine, Department of Preventive Medicine, Incheon, South Korea (GRID:grid.256155.0) (ISNI:0000 0004 0647 2973)